港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

同源康醫藥-B

3.730

+0.66021.50%

成交量：655.80萬

成交額：2,260.58萬

市值：14.18億

市盈率：-3.99

高：3.750

開：3.190

低：3.175

收：3.070

52周最高：22.560

52周最低：2.410

股本：3.80億

香港流通股本：3.75億

量比：0.73

換手率：1.75%

股息：- -

股息率：- -

每股收益(LYR):-0.935

淨資產收益率：-70.66%

總資產收益率：-28.19%

市淨率：4.65

市盈率(LYR):-3.99

市銷率: 11335.73

資料載入中...

總覽公司新聞資訊公告

同源康醫藥－Ｂ(02410)股價上升5.029%，現價港幣$6.37

阿斯达克财经

同源康醫藥-B 8月無新增發行或股份變動

港股異動 | 同源康醫藥-B(02410)午後升逾9% EGFR-TKI氘申艾替尼獲批一線治療晚期非小細胞肺癌

同源康(02410.HK)1類新藥氘申艾替尼片獲批附條件上市，為EGFR突變肺癌腦轉移臨床治療帶來新選擇

同源康醫藥-B早盤高開近15% 創新藥TY-9591片獲批准附條件上市

港股異動 | 同源康醫藥-B(02410.HK)高開近15% 創新藥TY-9591片獲批准附條件上市

同源康醫藥-B（02410）自主研發EGFR-TKI甲磺酸氘申艾替尼片獲NMPA附條件上市批准

同源康醫藥-B(02410)：國家藥品監督管理局附條件批准甲磺酸氘申艾替尼片(TY-9591片)的上市申請

同源康醫藥-B：甲磺酸阿桑德替尼片（TY-9591）獲國家藥監局附條件批准上市

創新藥概念局部走強翰森製藥（03692）漲15.00%、樂普生物（02157）漲2.64%

同源康醫藥-B（02410）將63,222,744股H股發行最後截止日期延至2026年9月20日

港股異動 | 同源康醫藥-B(02410)早盤升逾6% 上半年虧損顯著收窄 TY-9591商業化加速

智通财经网

同源康醫藥－Ｂ(02410)股價上升5.037%，現價港幣$7.09

阿斯达克财经

同源康醫藥-B(02410)上半年虧損大幅收窄產業化及商業化佈局持續取得進展

同源康醫藥-B（02410）披露董事會及四大委員會最新組成

同源康醫藥-B(02410.HK)：蔣鳴昱辭任非執行董事

同源康醫藥-B（02410）發布董事會變動及建議重選董事公告

創新藥概念繼續走強金斯瑞生物科技（01548）漲6.87% 機構指中國創新藥全球地位持續提升

同源康醫藥-B（02410）將於8月17日召開董事會審議2026年中期業績

同源康醫藥-B更新7月股份變動月報表，股本維持穩定

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/02410/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康醫藥-B","latestPrice":3.73,"timestamp":1789459707683,"preClose":3.07,"halted":0,"volume":6558000,"delay":0,"changeRate":0.21498371335504893,"floatShares":375457818,"shares":380065818,"eps":-0.935027769933164,"marketStatus":"未開盤","change":0.66,"latestTime":"09-15 16:08:27","open":3.19,"high":3.75,"low":3.175,"amount":22605812,"amplitude":0.187296,"askPrice":3.73,"askSize":11500,"bidPrice":3.7,"bidSize":13000,"shortable":0,"etf":0,"ttmEps":-0.6562901477925257,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789522200000},"marketStatusCode":0,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":3.07,"openAndCloseTimeList":[[1789435800000,1789444800000],[1789448400000,1789459200000]],"volumeRatio":0.730827,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":375457818,"roa":"-28.19%","roe":"-70.66%","lyrEps":-0.935028,"volumeRatio":0.730827,"shares":380065818,"dividePrice":0,"high":3.75,"amplitude":0.187296,"preClose":3.07,"low":3.175,"week52Low":2.41,"pbRate":"4.65","psRate":"11335.73","week52High":22.56,"institutionHeld":0,"latestPrice":3.73,"committee":0.061224,"eps":-0.935027769933164,"divideRate":0,"volume":6558000,"delay":0,"ttmEps":-0.6562901477925257,"open":3.19,"prevYearClose":13.11,"prevWeekClose":2.985,"prevMonthClose":5.56,"prevQuarterClose":5.73,"fiveDayClose":3.7,"twentyDayClose":7.1,"sixtyDayClose":6.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2026-08-17","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786930200000,"name":null,"time":"","dateTimestamp":1786896000000,"actualEps":null},{"date":"2026-03-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-31","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756603800000,"name":null,"time":"","dateTimestamp":1756569600000,"actualEps":null},{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2026-09-14","current":-5.683901,"percent":0.996063,"low":-45.171338,"twenty":-23.828083,"median":-16.950558,"eighty":-11.87963,"high":-4.152623,"avg":-17.785896,"sd":7.291302,"marketCap":1180948621},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995},{"date":"2025-05-02","current":-30.859428,"twenty":-28.772127,"median":-24.368612,"eighty":-19.308976,"marketCap":12738210348},{"date":"2025-05-09","current":-26.222368,"twenty":-28.789228,"median":-24.487968,"eighty":-19.376573,"marketCap":11477368567},{"date":"2025-05-16","current":-19.875071,"twenty":-28.703724,"median":-24.44033,"eighty":-19.45318,"marketCap":8770267095},{"date":"2025-05-23","current":-18.391406,"twenty":-28.460584,"median":-24.320388,"eighty":-19.147078,"marketCap":8139846205},{"date":"2025-05-30","current":-16.767615,"twenty":-28.328721,"median":-24.116277,"eighty":-18.777931,"marketCap":7453799941},{"date":"2025-06-06","current":-19.720458,"twenty":-27.077703,"median":-23.93026,"eighty":-18.847277,"marketCap":8788808886},{"date":"2025-06-13","current":-16.18601,"twenty":-26.697665,"median":-23.850097,"eighty":-18.709822,"marketCap":7216465018},{"date":"2025-06-20","current":-14.05098,"twenty":-26.664525,"median":-23.778892,"eighty":-18.426653,"marketCap":6252291891},{"date":"2025-06-27","current":-16.3221,"twenty":-26.630078,"median":-23.66211,"eighty":-18.32609,"marketCap":7283215465},{"date":"2025-07-04","current":-17.493079,"twenty":-26.41078,"median":-23.623818,"eighty":-18.194509,"marketCap":7806093968},{"date":"2025-07-11","current":-16.487526,"twenty":-26.267076,"median":-23.430941,"eighty":-17.964216,"marketCap":7349965912},{"date":"2025-07-18","current":-15.867745,"twenty":-26.226866,"median":-23.321155,"eighty":-17.866761,"marketCap":7068130691},{"date":"2025-07-25","current":-16.407488,"twenty":-26.143659,"median":-23.070409,"eighty":-17.335488,"marketCap":7335132480},{"date":"2025-08-01","current":-14.539711,"twenty":-26.072617,"median":-22.868028,"eighty":-17.325642,"marketCap":6459959949},{"date":"2025-08-08","current":-15.316665,"twenty":-25.987382,"median":-22.563641,"eighty":-17.04089,"marketCap":6822181433},{"date":"2025-08-15","current":-17.450454,"twenty":-25.968574,"median":-22.406203,"eighty":-16.915178,"marketCap":7760944003},{"date":"2025-08-22","current":-13.484776,"twenty":-25.95357,"median":-22.354126,"eighty":-16.718364,"marketCap":5978435317},{"date":"2025-08-29","current":-12.516323,"twenty":-25.925655,"median":-21.46252,"eighty":-16.486483,"marketCap":5575565550},{"date":"2025-09-05","current":-19.23268,"twenty":-25.919389,"median":-21.226743,"eighty":-16.486483,"marketCap":5883418862},{"date":"2025-09-12","current":-18.156363,"twenty":-25.850806,"median":-20.678772,"eighty":-16.541494,"marketCap":5564163575},{"date":"2025-09-19","current":-18.839434,"twenty":-25.807696,"median":-20.500943,"eighty":-16.56352,"marketCap":5769399117},{"date":"2025-09-26","current":-19.348832,"twenty":-25.743581,"median":-20.268382,"eighty":-16.654406,"marketCap":5910023469},{"date":"2025-10-03","current":-22.468168,"twenty":-25.650075,"median":-20.314843,"eighty":-16.707921,"marketCap":6879191305},{"date":"2025-10-10","current":-19.927643,"twenty":-25.596841,"median":-20.323115,"eighty":-16.732368,"marketCap":6092455062},{"date":"2025-10-17","current":-19.134493,"twenty":-25.519561,"median":-20.155539,"eighty":-16.749672,"marketCap":5845412280},{"date":"2025-10-24","current":-17.635142,"twenty":-25.404318,"median":-19.980008,"eighty":-16.781291,"marketCap":5389333299},{"date":"2025-10-31","current":-19.024541,"twenty":-25.400784,"median":-19.927643,"eighty":-16.830147,"marketCap":5822608331},{"date":"2025-11-07","current":-17.694439,"twenty":-25.37593,"median":-19.869193,"eighty":-16.945559,"marketCap":5412137248},{"date":"2025-11-14","current":-17.099248,"twenty":-25.321084,"median":-19.741813,"eighty":-16.951188,"marketCap":5244908288},{"date":"2025-11-21","current":-15.19815,"twenty":-25.311733,"median":-19.694587,"eighty":-16.919035,"marketCap":4659606928},{"date":"2025-11-28","current":-16.711808,"twenty":-25.293455,"median":-19.641679,"eighty":-16.730587,"marketCap":5142290517},{"date":"2025-12-05","current":-17.262657,"twenty":-25.275139,"median":-19.635782,"eighty":-16.587841,"marketCap":5320921452},{"date":"2025-12-12","current":-16.160016,"twenty":-25.213434,"median":-19.544821,"eighty":-16.497144,"marketCap":4990264190},{"date":"2025-12-19","current":-16.355316,"twenty":-25.19336,"median":-19.414876,"eighty":-16.454475,"marketCap":5062476695},{"date":"2025-12-24","current":-15.692499,"twenty":-25.154877,"median":-19.348832,"eighty":-16.406101,"marketCap":4872443786},{"date":"2026-01-02","current":-15.765099,"twenty":-25.10227,"median":-19.292077,"eighty":-16.35327,"marketCap":4914251026},{"date":"2026-01-09","current":-17.392186,"twenty":-25.070347,"median":-19.235279,"eighty":-16.345574,"marketCap":5434941197},{"date":"2026-01-16","current":-16.438751,"twenty":-25.06473,"median":-19.137216,"eighty":-16.35327,"marketCap":5153692492},{"date":"2026-01-23","current":-15.75073,"twenty":-25.023112,"median":-19.120814,"eighty":-16.314941,"marketCap":4933254317},{"date":"2026-01-30","current":-15.280433,"twenty":-24.971672,"median":-19.022068,"eighty":-16.22453,"marketCap":4807832597},{"date":"2026-02-06","current":-15.542994,"twenty":-24.952303,"median":-18.937078,"eighty":-16.152588,"marketCap":4902849052},{"date":"2026-02-13","current":-15.334427,"twenty":-24.923448,"median":-18.860882,"eighty":-16.099082,"marketCap":4864842470},{"date":"2026-02-20","current":-15.572498,"twenty":-24.905533,"median":-18.847277,"eighty":-16.071561,"marketCap":4933254317},{"date":"2026-02-27","current":-14.952615,"twenty":-24.827654,"median":-18.801141,"eighty":-15.988536,"marketCap":4788829306},{"date":"2026-03-06","current":-13.279596,"twenty":-24.77147,"median":-18.709822,"eighty":-15.892604,"marketCap":4218730579},{"date":"2026-03-13","current":-12.861452,"twenty":-24.760877,"median":-18.616931,"eighty":-15.828013,"marketCap":4104710834},{"date":"2026-03-20","current":-12.157235,"twenty":-24.758022,"median":-18.440891,"eighty":-15.765099,"marketCap":3865269369},{"date":"2026-03-27","current":-12.164275,"twenty":-24.758022,"median":-18.409208,"eighty":-15.692499,"marketCap":3857668052},{"date":"2026-04-02","current":-12.25818,"twenty":-24.73228,"median":-18.399621,"eighty":-15.606124,"marketCap":4180723998},{"date":"2026-04-10","current":-12.412577,"twenty":-24.72344,"median":-18.391406,"eighty":-15.554796,"marketCap":4266032641},{"date":"2026-04-17","current":-12.351427,"twenty":-24.717087,"median":-18.309793,"eighty":-15.461655,"marketCap":4246798950},{"date":"2026-04-24","current":-11.422185,"twenty":-24.709149,"median":-18.216326,"eighty":-15.337994,"marketCap":3927519681},{"date":"2026-04-30","current":-11.117278,"twenty":-24.702871,"median":-18.174743,"eighty":-15.304685,"marketCap":3823657750},{"date":"2026-05-08","current":-10.777891,"twenty":-24.684547,"median":-18.056929,"eighty":-15.189837,"marketCap":3719795820},{"date":"2026-05-15","current":-9.293361,"twenty":-24.617578,"median":-17.965815,"eighty":-15.119492,"marketCap":3215873118},{"date":"2026-05-22","current":-8.991533,"twenty":-24.605712,"median":-17.939574,"eighty":-15.043492,"marketCap":3104317711},{"date":"2026-05-29","current":-10.14843,"twenty":-24.599189,"median":-17.918048,"eighty":-14.961326,"marketCap":3515918696},{"date":"2026-06-05","current":-8.237808,"twenty":-24.571342,"median":-17.89208,"eighty":-14.895383,"marketCap":2858126467},{"date":"2026-06-12","current":-7.644268,"twenty":-24.535606,"median":-17.732128,"eighty":-14.684931,"marketCap":2650402606},{"date":"2026-06-18","current":-6.884404,"twenty":-24.459385,"median":-17.688347,"eighty":-14.384241,"marketCap":2392671147},{"date":"2026-06-26","current":-6.195227,"twenty":-24.397853,"median":-17.672452,"eighty":-13.470121,"marketCap":2142633166},{"date":"2026-07-03","current":-7.179757,"twenty":-24.364887,"median":-17.499062,"eighty":-13.369605,"marketCap":2484992864},{"date":"2026-07-10","current":-8.078806,"twenty":-24.314468,"median":-17.476751,"eighty":-13.262753,"marketCap":2792731918},{"date":"2026-07-17","current":-8.127776,"twenty":-24.232724,"median":-17.419476,"eighty":-13.079412,"marketCap":2819659085},{"date":"2026-07-24","current":-7.604914,"twenty":-24.150839,"median":-17.377721,"eighty":-12.93356,"marketCap":2638862391},{"date":"2026-07-31","current":-7.53517,"twenty":-24.119743,"median":-17.333807,"eighty":-12.87079,"marketCap":2619628700},{"date":"2026-08-07","current":-7.625479,"twenty":-24.07756,"median":-17.320685,"eighty":-12.528428,"marketCap":2656172713},{"date":"2026-08-14","current":-7.417307,"twenty":-24.00283,"median":-17.276309,"eighty":-12.375887,"marketCap":2586931426},{"date":"2026-08-21","current":-10.34776,"twenty":-23.939778,"median":-17.197085,"eighty":-12.303816,"marketCap":2563850996},{"date":"2026-08-28","current":-9.732294,"twenty":-23.880566,"median":-17.053511,"eighty":-12.176647,"marketCap":2411904838},{"date":"2026-09-04","current":-9.627537,"twenty":-23.866484,"median":-17.033052,"eighty":-12.068009,"marketCap":2386901040},{"date":"2026-09-11","current":-4.625216,"twenty":-23.835421,"median":-16.952134,"eighty":-11.905172,"marketCap":1148251346},{"date":"2026-09-14","current":-4.757028,"twenty":-23.828083,"median":-16.950558,"eighty":-11.87963,"marketCap":1180948621}],"updateTime":1789472656542},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664381726","title":"同源康醫藥－Ｂ(02410)股價上升5.029%，現價港幣$6.37","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381726","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381726?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 14:05","pubTimestamp":1788501900,"startTime":"0","endTime":"0","summary":"[上升股]同源康医药－Ｂ(02410) 股价在下午02:05比前收市价上升5.029%，现股价为港币$6.37。至目前为止，今日最高价为$6.37，而最低价为$6.065。总成交量为410.589万股，总成交金额为港币$2.551千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609046129/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609046129/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09939","BK1515","159938","BK1161","BK1574","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187462223","title":"同源康醫藥-B 8月無新增發行或股份變動","url":"https://stock-news.laohu8.com/highlight/detail?id=1187462223","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187462223?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 16:49","pubTimestamp":1788425388,"startTime":"0","endTime":"0","summary":"2026年9月3日，浙江同源康医药股份有限公司（股票代码：02410，股票简称“同源康医药-B”）发布2026年8月股份变动月报表。公告显示，截至2026年8月31日，公司注册股本总额为人民币380,065,818元，普通股H股共计380,065,818股，面值均为人民币1元，较上月底无任何增减变动。\n公告同时明确，当月未发生新发行、购回、注销或库藏股变动，也无股份期权或其他股权激励计划调整。截至8月底，公司已发行股份数为380,065,818股，公众持股量符合香港联合交易所相关规定，整体股本结构保持稳定。本次公告由执行董事、董事长兼总裁吴豫生签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664824858","title":"港股異動 | 同源康醫藥-B(02410)午後升逾9% EGFR-TKI氘申艾替尼獲批一線治療晚期非小細胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2664824858","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664824858?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 14:30","pubTimestamp":1788417020,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B午后涨超9%。消息面上，同源康医药近日宣布，公司自主研发的新一代EGFR-TKI创新药甲磺酸氘申艾替尼片已正式获得中国国家药品监督管理局批准附条件上市，适应症为具有表皮生长因子受体外显子19缺失或外显子21置换突变，并伴有中枢神经系统转移的局部晚期或转移性非小细胞肺癌成人患者的一线治疗。同源康预计收取7亿元人民币现金首付款及股份认购款，以及最高20.6亿元人民币的注册里程碑付款。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02410","BK4585","BK4588","BK1515","VXUS","159938","09939","KCAI","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662058394","title":"同源康(02410.HK)1類新藥氘申艾替尼片獲批附條件上市，為EGFR突變肺癌腦轉移臨床治療帶來新選擇","url":"https://stock-news.laohu8.com/highlight/detail?id=2662058394","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662058394?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 10:27","pubTimestamp":1787884074,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662037097","title":"同源康醫藥-B早盤高開近15% 創新藥TY-9591片獲批准附條件上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2662037097","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662037097?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 09:35","pubTimestamp":1787880900,"startTime":"0","endTime":"0","summary":"模拟交易客户端同源康医药-B早盘高开近15%，截至发稿，股价上涨14.99%，现报7.825港元，成交额275.83万港元。8月27日晚，同源康医药公布，公司自主研发的新一代EGFR-TKI创新药甲磺酸氘申艾替尼片已获得中国国家药品监督管理局批准附条件上市，适应症为具有表皮生长因子受体外显子19缺失或外显子21置换突变，并伴有中枢神经系统转移的局部晚期或转移性非小细胞肺癌成人患者的一线治疗。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-28/doc-inipvrtx8899235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02410","MEDX","06978","BK1161","BK1574","159938","LNGR","09939","IPOS","BK1515","IBBQ","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662037468","title":"港股異動 | 同源康醫藥-B(02410.HK)高開近15% 創新藥TY-9591片獲批准附條件上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2662037468","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662037468?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 09:24","pubTimestamp":1787880257,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02410","BK1574","BK1161","BK1515","06978","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151775479","title":"同源康醫藥-B（02410）自主研發EGFR-TKI甲磺酸氘申艾替尼片獲NMPA附條件上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1151775479","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151775479?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 21:24","pubTimestamp":1787837048,"startTime":"0","endTime":"0","summary":"2026年8月27日，同源康医药-B发布自愿公告称，其自主研发的新一代EGFR-TKI创新药甲磺酸氘申艾替尼片已获得中国国家药品监督管理局附条件上市批准。该药适用于携带表皮生长因子受体外显子19缺失或外显子21置换突变，并伴有中枢神经系统转移的局部晚期或转移性非小细胞肺癌成人患者的一线治疗。同源康医药-B提醒，尚无法保证甲磺酸氘申艾替尼片最终能够成功商业化，投资者买卖公司股份时需审慎行事。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662881040","title":"同源康醫藥-B(02410)：國家藥品監督管理局附條件批准甲磺酸氘申艾替尼片(TY-9591片)的上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2662881040","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662881040?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 21:18","pubTimestamp":1787836724,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B 发布公告，本公司自主研发的新一代EGFR-TKI创新药甲磺酸氘申艾替尼片已获得中国国家药品监督管理局批准附条件上市，适应症为具有表皮生长因子受体外显子19缺失或外显子21置换突变，并伴有中枢神经系统转移的局部晚期或转移性非小细胞肺癌成人患者的一线治疗。甲磺酸氘申艾替尼片是本公司自主研发的新一代高选择性、不可逆口服 EGFR-TKI，为奥希替尼差异化氘代创新品种。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487410.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","IPOS","09939","BK1515","02410","BK1161","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194356135","title":"同源康醫藥-B：甲磺酸阿桑德替尼片（TY-9591）獲國家藥監局附條件批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1194356135","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194356135?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 21:17","pubTimestamp":1787836630,"startTime":"0","endTime":"0","summary":"同源康医药-B宣布，其自主研发的甲磺酸阿桑德替尼片已正式获得国家药品监督管理局的附条件批准上市许可。据悉，此次获批是基于其显著的临床疗效和可控的安全性数据。附条件批准意味着，在现有证据支持药物临床价值的前提下，企业仍需按监管要求完成后续的验证性临床试验。业内分析认为，TY-9591的获批不仅丰富了同源康医药的研发管线，也为其在精准医疗领域的布局增添了重要砝码。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662721761","title":"創新藥概念局部走強 翰森製藥（03692）漲15.00%、樂普生物（02157）漲2.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662721761","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662721761?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 10:13","pubTimestamp":1787796798,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股抗肿瘤板块盘初强势，截至发稿，翰森制药 涨15.00%，乐普生物涨2.64%，康方生物涨2.28%，石四药集团涨2.08%，同源康医药-B涨1.00%，荣昌生物涨0.87%。消息面上，2026年生物医药行业站在“十五五”开局与全球专利悬崖叠加的关键节点。上海证券认为，《国民健康“十五五”规划》、《全民医疗保障“十五五”规划》近期相继发布，政策明确发展目标及实施要求，全链条创新药械支持体系持续完善。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989649","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU0417516902.SGD","BK1583","MEDX","LU2476274308.USD","LU0348767384.USD","02005","IE00B5MMRT66.SGD","03692","02410","LU0348827113.USD","LU1969619763.USD","LU0417516738.SGD","BK1191","LU0417516571.SGD","LU1961090484.USD","LU2460026573.USD","LU2476274720.SGD","LU2488822045.USD","LU1720050803.USD","09995","LU0634319403.HKD","LU1794554557.SGD","LU2399975544.HKD","IE00B543WZ88.USD","159992","LU0540923850.HKD","LU0348784397.USD","LU0348735423.USD","LU0561508036.HKD","LU2328871848.SGD","LU0348766576.USD","BK1161","IBBQ","06978","KURE","LU2778985437.USD","BK1574","09926","LU0348783233.USD","IE00BPRC5H50.USD","02157","LU0348825331.USD","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117102070","title":"同源康醫藥-B（02410）將63,222,744股H股發行最後截止日期延至2026年9月20日","url":"https://stock-news.laohu8.com/highlight/detail?id=1117102070","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117102070?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 19:21","pubTimestamp":1787224881,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司8月20日发布公告称，公司与齐鲁方面就许可及合作事项下拟向认购方发行63,222,744股H股的认购协议，最后截止日期由2026年8月20日顺延至2026年9月20日。根据2026年7月21日公告，该认购事项须在认购协议项下的先决条件达成或获得豁免后方可完成；若相关条件未能在最后截止日期前落实，认购协议将被终止。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660459889","title":"港股異動 | 同源康醫藥-B(02410)早盤升逾6% 上半年虧損顯著收窄 TY-9591商業化加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2660459889","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660459889?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 11:05","pubTimestamp":1787022306,"startTime":"0","endTime":"0","summary":"同源康医药-B(02410)早盘涨超6%，截至发稿，涨5.63%，报7.13港元，成交额1614.64万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260818/20260818110837_92055.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260818/20260818110837_92055.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["KCAI","02410","BK1574","BK4588","TY","BK1161","BK1515","BK4585","159938","09939","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660598564","title":"同源康醫藥－Ｂ(02410)股價上升5.037%，現價港幣$7.09","url":"https://stock-news.laohu8.com/highlight/detail?id=2660598564","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660598564?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 10:54","pubTimestamp":1787021640,"startTime":"0","endTime":"0","summary":"[上升股]同源康医药－Ｂ(02410) 股价在上午10:53比前收市价上升5.037%，现股价为港币$7.09。至目前为止，今日最高价为$7.09，而最低价为$6.62。总成交量为162.6万股，总成交金额为港币$1.124千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608181390/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608181390/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02410","BK1161","BK1574","159938","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660806764","title":"同源康醫藥-B(02410)上半年虧損大幅收窄 產業化及商業化佈局持續取得進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2660806764","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660806764?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 20:39","pubTimestamp":1786970394,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B 公布2026年中期业绩，研发成本为9494.3万元，同比增长7%;行政开支6255.4万元，同比增长61.3%;母公司拥有人应占亏损2489.7万元，同比收窄77.81%。此外，公司于2026年1月获浙江省药品监督管理局颁发的《药品生产许可证》。本次获得药品生产许可证，预期将对公司扩大产能及拓展市场产生长远的积极作用，为后续开展商业化生产奠定基础。此举为公司透过借助齐鲁的专业知识及网路达成其商业化里程碑的重要举措。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02410","09939","BK1574","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105087400","title":"同源康醫藥-B（02410）披露董事會及四大委員會最新組成","url":"https://stock-news.laohu8.com/highlight/detail?id=1105087400","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105087400?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 20:16","pubTimestamp":1786968984,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司8月17日公告，公司董事会由九名董事组成，其中执行董事1名、非执行董事4名、独立非执行董事4名。本次公告日期为2026年8月17日，公司未对上述董事及委员会设置作出其他补充说明。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660504487","title":"同源康醫藥-B(02410.HK)：蔣鳴昱辭任非執行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2660504487","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660504487?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 20:10","pubTimestamp":1786968601,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1515","02410","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182291744","title":"同源康醫藥-B（02410）發布董事會變動及建議重選董事公告","url":"https://stock-news.laohu8.com/highlight/detail?id=1182291744","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182291744?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 20:06","pubTimestamp":1786968373,"startTime":"0","endTime":"0","summary":"8月17日，同源康医药-B公告称，公司董事会收到蔣鸣昱博士的辞呈，其因投放更多时间从事其他商业事务，已辞任非执行董事及根据香港联交所证券上市规则第3.05条规定的授权代表，辞任自2026年8月17日起生效。蔣博士确认无任何与董事会及公司之间的意见分歧，亦无任何需提请股东及联交所关注的事项。董事会对其任职期间的贡献表示感谢。此外，公司将适时向股东派发载有建议重选董事详细资料的通函。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658369969","title":"創新藥概念繼續走強 金斯瑞生物科技（01548）漲6.87% 機構指中國創新藥全球地位持續提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2658369969","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658369969?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:15","pubTimestamp":1786418137,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股创新药概念持续走强，截至发稿，金斯瑞生物科技 涨6.87%，再鼎医药涨5.51%，同源康医药-B涨4.81%，晶泰控股涨3.94%，药明合联涨3.92%，翰森制药涨3.76%，亚盛医药涨3.63%，百济神州涨3.38%，药明康德涨3.03%，诺诚健华涨2.83%，石药集团涨2.78%。国元国际证券亦表示，出海交易量价齐升，中国创新药全球地位持续提升。中国创新药出海持续超预期，上半年997亿美元的交易总额和全球TOP10中独占8席的成绩，充分验证了中国创新药资产的全球竞争力。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987912","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359","HK0000320223.HKD","02268","LU0072913022.USD","LU0326950275.SGD","LU2039709279.SGD","06160","BK1161","LU1152091168.USD","IE00BZ08YS42.EUR","09969","02228","IE00BZ08YT58.USD","LU1813983027.USD","HK0000306685.HKD","01093","02410","LNGR","IE00B5MMRT66.SGD","LU0315179316.USD","06855","03692","KURE","09688","BK1576","LU2488822045.USD","LU1303224171.USD","LU2125910500.SGD","MEDX","BK1521","BK1617","LU2242644610.SGD","IE00BZ08YR35.GBP","LU0880133367.SGD","BK1515","LU1226288170.HKD","LU1993786604.SGD","LU1951186391.HKD","LU1226287875.USD","BK1588","IE00B543WZ88.USD","BK1583","BK1500","IBBQ","LU2328871848.SGD","06978","IE00B031HY20.USD","01548","159992","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104587482","title":"同源康醫藥-B（02410）將於8月17日召開董事會審議2026年中期業績","url":"https://stock-news.laohu8.com/highlight/detail?id=1104587482","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104587482?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 17:22","pubTimestamp":1785921722,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司（股票代码：02410，股票简称：同源康医药-B）8月5日公告称，公司董事会会议将于2026年8月17日（星期一）举行。届时，董事会将审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩，并讨论是否派发中期股息（如有）。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120386864","title":"同源康醫藥-B更新7月股份變動月報表，股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1120386864","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120386864?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 17:11","pubTimestamp":1785921109,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司（同源康医药-B，股票代码：02410）于2026年8月5日发布截至2026年7月31日的股份变动月报表。报告显示，公司期末注册股本为人民币380,065,818元，各类已发行普通股合计380,065,818股，面值每股人民币1元，库藏股数量为0股。\n报告期内，公司无新增发行、购回、注销或库藏股变动，股本结构保持稳定。公司亦表示，其已满足香港联交所对于上市发行人最低公眾持股量不低于该类别股份总数的25%之规定。根据公告信息，本次月报由执行董事、董事长兼总裁吴豫生签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":76,"code":"91000000","status":"200"}]}}